Attention-Deficit/Hyperactivity Disorder (ADHD): psychiatric comorbidity and pharmacological treatment alternative to methylphenidate

Authors:

Díez Suárez A^a, Figueroa Quintana A^b, Soutullo Esperón C^c

Reference of this article.:

Díez Suárez A, Figueroa Quintana A, Soutullo Esperón C. Trastorno por déficit de atención e hiperactividad (TDAH): comorbilidad psiquiátrica y tratamiento farmacológico alternativo al metilfenidato. Rev Pediatr Aten Primaria. 2006;8 Supl 4:S135-55.

Published in Internet: 31/12/2006

Abstract:

About half of children and adolescents with ADHD suffer at least from another psychiatric condition, making more difficult both diagnosis and treatment, and worsening outcome. Psychiatric conditions more frequently associated with ADHD are: disruptive behaviour disorder, anxiety disorder and mood disorder. Regarding pharmacological treatment alternatives to methylphenidate, the non-stimulant drug with more scientific data supporting its efficacy and safety in children and adolescents wit ADHD is atomoxetine, and it is the only drug recommended as first choice, as well as stimulants. Among the rest of non-stimulant treatments, tricyclic antidepressants are the next drugs having more data supporting their efficacy, although they have more safety problems.

Keywords: Comorbidity. ADH/D. Atomoxetin. Child psychiatry.

El contenido íntegro del artículo estará disponible en formato web próximamente. Mientras tanto puede descargarlo en formato Acrobat Reader (PDF).